QT prolongation and sudden cardiac death risk in hypertrophic cardiomyopathy

被引:20
作者
Patel, Salma, I [1 ]
Ackerman, Michael J. [2 ]
Shamounc, Fadi E. [3 ]
Geske, Jeffrey B. [2 ]
Ommen, Steve R. [2 ]
Love, William T. [4 ]
Cha, Stephen S. [5 ]
Bos, Johan M. [2 ]
Lester, Steven J. [3 ]
机构
[1] Mayo Clin, Ctr Sleep Med, Rochester, MN USA
[2] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN USA
[3] Mayo Clin, Div Cardiovasc Dis, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA
[4] Mayo Clin, Dept Internal Med, Scottsdale, AZ 85259 USA
[5] Mayo Clin, Dept Hlth Sci Res, Scottsdale, AZ 85259 USA
关键词
Hypertrophic cardiomyopathy; sudden cardiac death; Holter; electrocardiography; QTc; 2011 ACCF/AHA GUIDELINE; ASSOCIATION TASK-FORCE; HEART-ASSOCIATION; DISPERSION; PREVALENCE; DIAGNOSIS; MODEL;
D O I
10.1080/00015385.2018.1440905
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Risk assessment for sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM) remains complex. The goal of this study was to assess electrocardiogram (ECG)-derived risk factors on SCD in a large HCM population Methods: Retrospective review of adults with HCM evaluated at Mayo Clinic, Rochester, MN from 1 December 2002 to 31 December 2012 was performed. Data inclusive of ECG and 24-hour ambulatory Holter monitor were assessed. SCD events were documented by ventricular fibrillation (VF) noted on implantable cardioverter defibrillator (ICD), or appropriate VT or VF-terminating ICD shock. Results: Overall, 1615 patients (mean age 53.7 +/- 15.2 years; 943 males, 58.4%) were assessed, with mean follow-up 2.46 years and 110 SCD events. Via logistic regression (n = 820), the odds of SCD increased with increasing number of conventional risk factors. With one risk factor the OR was 4.88 (p <.0001; CI 2.22-10.74), two risk factors the OR was 6.922 (p<.0001; CI 2.94-16.28) and three or more risk factors, the OR was 13.997 (p < .0001; CI 5.649-34.68). Adding QTc > 450 to this logistic regression model had OR 1.722 (p = .04, CI 1.01-2.937) to predict SCD. QTc >= 450 was a significant predictor for death (HR 1.88, p= .021, 0 1.10-3.20). There was no correlation between sinus bradycardia, sinus tachycardia, first degree AV block, atrial fibrillation, left bundle branch block, right bundle branch block, premature atrial complexes, premature ventricular complexes, supraventricular tachycardia, PR interval, QRS interval and SCD. Conclusions: Prolonged QTc was a risk factor for SCD and death even when controlling for typical risk factors.
引用
收藏
页码:53 / 58
页数:6
相关论文
共 14 条
[1]  
DAY CP, 1990, BRIT HEART J, V63, P342
[2]   QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy [J].
Debonnaire, Philippe ;
Katsanos, Spyridon ;
Joyce, Emer ;
Van den Brink, Olivier V. W. ;
Atsma, Douwe E. ;
Schalij, Martin J. ;
Bax, Jeroen J. ;
Delgado, Victoria ;
Marsan, Nina Ajmone .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2015, 26 (05) :547-555
[3]   Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? [J].
Ellenbogen, KA ;
Levine, JH ;
Berger, RD ;
Daubert, JP ;
Winters, SL ;
Greenstein, E ;
Shalaby, A ;
Schaechter, A ;
Subacius, H ;
Kadish, A .
CIRCULATION, 2006, 113 (06) :776-782
[4]   Is QT dispersion associated with sudden cardiac death in patients with hypertrophic cardiomyopathy? [J].
Gang, Y ;
Poloniecki, J ;
Dickie, S ;
Elliott, PM ;
Malik, M ;
McKenna, WJ .
ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2001, 6 (03) :209-215
[5]  
Gersh BJ, 2011, CIRCULATION, V124, P2761, DOI 10.1161/CIR.0b013e318223e230
[6]   2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [J].
Gersh, Bernard J. ;
Maron, Barry J. ;
Bonow, Robert O. ;
Dearani, Joseph A. ;
Fifer, Michael A. ;
Link, Mark S. ;
Naidu, Srihari S. ;
Nishimura, Rick A. ;
Ommen, Steve R. ;
Rakowski, Harry ;
Seidman, Christine E. ;
Towbin, Jeffrey A. ;
Udelson, James E. ;
Yancy, Clyde W. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (25) :2703-2738
[7]   Prolongation of the QTc Interval Predicts Appropriate Implantable Cardioverter-Defibrillator Therapies in Hypertrophic Cardiomyopathy [J].
Gray, Belinda ;
Ingles, Jodie ;
Medi, Caroline ;
Semsarian, Christopher .
JACC-HEART FAILURE, 2013, 1 (02) :149-155
[8]   Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy [J].
Johnson, Jonathan N. ;
Grifoni, Camilla ;
Bos, J. Martijn ;
Saber-Ayad, Maha ;
Ommen, Steve R. ;
Nistri, Stefano ;
Cecchi, Franco ;
Olivotto, Iacopo ;
Ackerman, Michael J. .
EUROPEAN HEART JOURNAL, 2011, 32 (09) :1114-1120
[9]   Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis A Scientific Statement From the American Heart Association and American College of Cardiology [J].
Maron, Barry J. ;
Udelson, James E. ;
Bonow, Robert O. ;
Nishimura, Rick A. ;
Ackerman, Michael J. ;
Estes, N. A. Mark, III ;
Cooper, Leslie T., Jr. ;
Link, Mark S. ;
Maron, Martin S. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (21) :2362-2371
[10]   Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy [J].
Maron, Barry J. ;
Casey, Susan A. ;
Chan, Raymond H. ;
Garberich, Ross F. ;
Rowin, Ethan J. ;
Maron, Martin S. .
AMERICAN JOURNAL OF CARDIOLOGY, 2015, 116 (05) :757-764